'Hold' Jubilant Pharmova Shares Maintains Systematix Post Inline Q2 Results - Check Target Price
0
Jubilant Pharmova's sterile CMO and allergy Immunotherapy posts strong growth in Q2.
Jubilant Pharmova's sterile CMO and allergy Immunotherapy posts strong growth in Q2.